Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

Therapeutics and Clinical Risk Management Volume 18, 2022 - Issue

Submit an article Journal homepage

Open access

267

Views

CrossRef citations to date

Altmetric

Review

An Evaluation of the Efficacy and Safety of Vibegron in the Treatment of Overactive Bladder

Jeffrey Frankel1 Seattle Urology Research Center, Seattle, WA, USACorrespondence[email protected]

David Staskin2 Tufts University School of Medicine, Boston, MA, USA

Susann Varano3 Clinical Research Consulting, Milford, CT, USA

Michael J Kennelly4 Carolinas Medical Center, Charlotte, NC, USA

Rachael A Jankowich5 Urovant Sciences, Irvine, CA, USA

Cornelia Haag-Molkenteller5 Urovant Sciences, Irvine, CA, USA

Pages 171-182 | Published online: 03 Mar 2022

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (2)

Shota Yamamoto, Hotaka Kusabuka, Akane Matsuzawa, Itaru Maruyama & Takanobu Yamazaki. (2023) Vibegron shows high selectivity and potent agonist activity for β3-adrenoceptors, irrespective of receptor density. PLOS ONE 18:9, pages e0290685.
Crossref

Caroline P. Babin, Nicole T. Catalano, David M. Yancey, Nathan Z. Pearl, Eleanor M. Koonce, Shahab Ahmadzadeh, Sahar Shekoohi, Elyse M. Cornett & Alan D. Kaye. (2023) Update on Overactive Bladder Therapeutic Options. American Journal of Therapeutics Publish Ahead of Print.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references